Shortages will affect non-pen injectable insulins through early weeks of April Over six million Americans ... Patients will have a harder time getting their Humalog and Insulin Lispro Injections at ...
The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$ 11.17 billion by 2032, from US$ 7.36 billion in 2023. The market is mainly driven by growth rate of diabetes ...